Histone Writers, Readers and Erasers: A Knockout Map

Most chromatin reviews are organized by mark: here is H3K27ac, here are its enzymes, here is what it means. That organization is useful for interpretation and awkward for experiments, because a knockout is a perturbation of an enzyme, not of a mark.

This article draws the map the other way round: enzyme first. For each major class, what the knockout is expected to do, where redundancy defeats it, and how to verify that the knockout actually changed the mark. Mark-level interpretation and the validation chain for epigenome editing are in our pillar; this piece is the enzyme-side companion.

Two patterns recur. Paralogue redundancy (KMT2 family, p300/CBP, SUV39 family) means single knockouts often show little mark change. Lethality (PRC2 components, p300/CBP) means the informative experiments are frequently knockdowns, inducible deletions, or differentiation-timed deletions rather than constitutive knockouts.

The key conceptual point: erasers are frequently scaffolds as well as catalysts. A knockout removes both functions, so a phenotype does not automatically implicate catalytic activity. The control that separates them is a catalytically dead knock-in — expensive, and the reason this distinction is often asserted rather than shown.

Readers bind modified residues and translate them into effects. They are where mark biology becomes mechanism, and they are the least amenable to knockout logic, because readers typically have many paralogues and bind several marks.

Practical guidance:

• • Domain-focused perturbation. Deleting a reader's bromodomain or chromodomain while keeping the protein can separate binding from scaffolding, and is often more informative than a null allele.
• • Bromodomain inhibition. Useful for acute perturbation (BRD4, BRD9), but remember that BET inhibitors displace readers genome-wide — a global effect is not evidence about a specific locus.
• • Combined read–write logic. A reader knockout that produces no mark change but a strong transcriptional phenotype is a signal that the reader, not the mark, is the functional unit in that context.

The third row is the strategic insight: if the question is about one locus, an enzyme knockout is the wrong instrument, because it changes thousands of loci at once. Chromatin-enzyme knockouts answer "what does this enzyme do in this cell", while targeted editors answer "what does this mark do at this element".

1. Genotype. Junction sequencing, zygosity, and for multi-exon enzymes confirmation that the deletion removes the catalytic domain.
2. Protein. Western with a validated antibody; for large enzymes, check for truncated species.
3. Catalytic output. Mark-level measurement by CUT&RUN or ChIP with spike-in normalization, at known target loci and at control regions. A knockout without a mark change is a result about redundancy, not a failed experiment — but it must be documented.
4. Compensatory changes. Check the paralogue and the opposing enzyme, because compensation is common and changes interpretation.
5. Phenotype context. Growth, morphology, and differentiation capacity, since many chromatin knockouts alter these and thereby alter marks indirectly.

EDITGENE supplies writer, eraser and reader knockout and degron lines with junction sequencing, zygosity, protein-absence confirmation, spike-in normalized mark measurements at target and control loci, and paralogue compensation checks.

Tell us the enzyme and the mark you plan to read. Contact EDITGENE to request a project consultation or quote.

Knockout phenotypes summarized here reflect commonly reported observations; severity, penetrance, and compensation vary by cell type and by knockout strategy.

Absence of a mark change does not establish that the enzyme is irrelevant — it may indicate redundancy or a non-catalytic function — and should be reported with the compensation analysis that supports the interpretation.

• • Zhao Z, Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biology. 2019;20:245.
• • Margueron R, Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature. 2011;469:343–349.
• • Hyun K, et al. Writing, erasing and reading histone lysine methylations. Experimental & Molecular Medicine. 2017;49:e324.
• • Skene PJ, Henikoff S. An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. eLife. 2017;6:e21856.
• • Gillette TG, Hill JA. Readers, writers, and erasers: chromatin as the whiteboard of heart disease. Circulation Research. 2015;116:1245–1253.